IL1B and gout: In the clinic, colchicine relieves gout inflammation by inhibiting MSU crystal activation in the NLRP3 inflammasome, thereby blocking the release of IL-1β.7 Anakinra, a recombinant human IL-1Ra, is the first biological agent approved for treatment of rheumatoid arthritis.